Quisel John D 4
4 · Disc Medicine, Inc. · Filed Jul 8, 2025
Insider Transaction Report
Form 4
Quisel John D
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-07-03$55.09/sh−5,200$286,454→ 161,828 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-07-03−5,200→ 150,175 totalExercise: $9.86Exp: 2031-09-13→ Common Stock (5,200 underlying) - Exercise/Conversion
Common Stock
2025-07-03$9.86/sh+5,200$51,272→ 167,028 total
Footnotes (3)
- [F1]The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
- [F3]The shares underlying this option vest in 48 equal monthly installments following September 1, 2021, subject to the Reporting Person's continued service on each such vesting date.